Clinical Trial Update: Propranolol for Challenging Behaviors in Autism [Phase 2]

View source ↗

Summary

Phase 2 trial of propranolol for challenging behaviors in autism has completed and posted results. The study evaluated aggression and self-injurious behavior in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Developmental Disability

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Autism Spectrum Disorder, Developmental Disability | Phase 2 | Status: COMPLETED | Results posted: 2025-06-04